Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Biphasic modulation of insulin signaling enables highly efficient hematopoietic differentiation from human pluripotent stem cells

Fig. 5

Bioinformatics analysis and characterization of differentiated CD34+CD43 and CD34+CD43+ cells. a GSEA enrichment plot of KEGG signaling pathways in H1 hESC-derived CD43+ and CD43 populations. Nominal P value, empirical phenotype-based permutation test (P < 0.05, FDR < 0.25). b Pearson correlation map of RNA-seq data of hematopoietic and endothelial-related factors from indicated populations in current study and published datasets. c PCA graph of CD34+CD43+ and CD34+CD43 cells derived from H1 hESCs and iPSCs and six kinds of cell types reported in related papers. d Colony-forming assay of day 8 CD43+CD34+ cells. Scale bars, 100 μm. e Frequency and percentage of different hematopoietic colonies after HSPCs replated into MethoCult medium for 2 weeks. f Wright–Giemsa staining of CD43+CD34+ cell-derived hematopoietic colonies. Scale bars, 25 μm. g Working model for biphasic modulation of insulin in regulating generation of hemogenic endothelium and hematopoietic progenitor cells. AE arterial endothelium, AGM aorta-gonad-mesonephros, CFU colony-forming unit, BFU burst-forming units, E erythroid, EB embryoid body, EC endothelial cell, FL fetal liver, M macrophage, G granulocyte, GM granulocyte–macrophage, HE hemogenic endothelium, hPSC human pluripotent stem cell, HSPC hematopoietic stem/progenitor cell, iPSC induced pluripotent stem cell, ME mesoderm cell, mixed myeloid–erythroid, PCA principal component analysis, TGFβ transforming growth factor beta, UCB umbilical cord blood, FDR false discovery rate

Back to article page